{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:19:02Z","timestamp":1788545942662,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,4]],"date-time":"2027-04-04T00:00:00Z","timestamp":1806796800000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jamda.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jamda.2026.106178","type":"journal-article","created":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:10:34Z","timestamp":1775304634000},"page":"106178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Prevalence of Central Nervous System-Active Polypharmacy in US Nursing Homes"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1246-7994","authenticated-orcid":false,"given":"Heeyoon","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao-Hsien","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne L.","family":"Hume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Dosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonggyu","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate L.","family":"Lapane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2026.106178_bib1","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/jgs.14759","article-title":"Central nervous system medication burden and serious Falls in older nursing home residents","volume":"65","author":"Hanlon","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106178_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1532-5415.2008.02127.x","article-title":"Impact of Central Nervous System (CNS) medication use on cognition decline in community dwelling older adults: findings from the health, aging and body composition study","volume":"57","author":"Wright","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106178_bib3","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.18372","article-title":"American Geriatrics Society 2023 updated AGS Beers Criteria\u00ae for potentially inappropriate medication use in older adults","volume":"71","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106178_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/geroni\/igaa018","article-title":"National partnership to improve dementia care in nursing homes campaign: state and facility strategies, impact, and antipsychotic reduction outcomes","volume":"4","author":"Crystal","year":"2020","journal-title":"Innov Aging"},{"key":"10.1016\/j.jamda.2026.106178_bib6","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC Clinical Practice Guideline for Prescribing Opioids for Pain \u2014 United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jamda.2026.106178_bib9","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1007\/s11606-025-09454-1","article-title":"Central nervous system\u2013active medication use in older adults with and without dementia\u2014a retrospective cohort study","volume":"40","author":"Warner","year":"2025","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jamda.2026.106178_bib10","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jamda.2020.04.029","article-title":"Time trends in opioid use by dementia severity in long-term care nursing home residents","volume":"22","author":"Mehta","year":"2021","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2026.106178_bib12","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1111\/jgs.14930","article-title":"Opioids and other central nervous system-active polypharmacy in older adults in the United States","volume":"65","author":"Gerlach","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106178_bib13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/jamainternmed.2016.9225","article-title":"Trends in central nervous system-active polypharmacy among older adults seen in outpatient care in the United States","volume":"177","author":"Maust","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jamda.2026.106178_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s40266-024-01178-x","article-title":"An educational intervention to promote central nervous system-active deprescribing in dementia: a pilot study","volume":"42","author":"Barnett","year":"2025","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2026.106178_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2025.105708","article-title":"Central nervous system polypharmacy among people living with dementia","volume":"26","author":"Bayliss","year":"2025","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2026.106178_bib16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/jgs.19256","article-title":"Clinician contributions to central nervous system-active polypharmacy among older adults with dementia in the United States","volume":"73","author":"Vordenberg","year":"2025","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106178_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1007\/s40266-023-01066-w","article-title":"Secular trends in central nervous system-active polypharmacy among serial cross-sections of US adults, 2009\u20132020","volume":"40","author":"Terman","year":"2023","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2026.106178_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1001\/jama.2021.1195","article-title":"Prevalence of central nervous system\u2013active polypharmacy among older adults with dementia in the US","volume":"325","author":"Maust","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2026.106178_bib19","first-page":"85","article-title":"Characterizing medicare medication therapy management program enrollees with central nervous system\u2013active polypharmacy","volume":"32","author":"Hung","year":"2026","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.jamda.2026.106178_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107261","article-title":"Polypharmacy in patients with epilepsy: a nationally representative cross-sectional study","volume":"111","author":"Terman","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jamda.2026.106178_bib21","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1177\/13524585241251986","article-title":"Trends in central nervous system-active polypharmacy among people with multiple sclerosis","volume":"30","author":"Naizer","year":"2024","journal-title":"Mult Scler"},{"key":"10.1016\/j.jamda.2026.106178_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13195-024-01405-y","article-title":"Prevalence and trend of central nervous system\u2013active medication polypharmacy among US commercially insured adults with vs without early-onset dementia: a multi-year cross-sectional study","volume":"16","author":"Wei","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.jamda.2026.106178_bib23","first-page":"294","article-title":"Medication costs and use of older Americans in assisted living settings: a nationally representative cross-sectional study","volume":"38","author":"Lei","year":"2022","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jamda.2026.106178_bib24","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1111\/jgs.70175","article-title":"Prevalence and duration of potential drug-drug interactions among US nursing home residents, 2018\u20132020","volume":"73","author":"Reich","year":"2025","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106178_bib26","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jamda.2012.06.002","article-title":"Making the investment count: revision of the minimum data set for nursing homes, MDS 3.0","volume":"13","author":"Saliba","year":"2012","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2026.106178_bib27","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/gps.5516","article-title":"Development and psychometric evaluation of the social connectedness index in nursing home residents with Alzheimer\u2019s disease and dementia using the minimum data set 3.0","volume":"36","author":"Bova","year":"2021","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2026.106178_bib28","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1097\/MLR.0000000000000334","article-title":"The minimum data set 3.0 cognitive function scale","volume":"55","author":"Thomas","year":"2017","journal-title":"Med Care"},{"key":"10.1016\/j.jamda.2026.106178_bib29","doi-asserted-by":"crossref","first-page":"M546","DOI":"10.1093\/gerona\/54.11.M546","article-title":"Scaling ADLs within the MDS","volume":"54","author":"Morris","year":"1999","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2026.106178_bib30","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jamda.2014.11.018","article-title":"Functional improvement among short-stay nursing home residents in the MDS 3.0","volume":"16","author":"Wysocki","year":"2015","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2026.106178_bib31","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/jgs.17172","article-title":"Trends in antipsychotic prescribing among long-term care residents receiving hospice care","volume":"69","author":"Gerlach","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106178_bib32","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/gerona\/glp215","article-title":"Correspondence of verbal descriptor and numeric rating scales for pain intensity: an item response theory calibration","volume":"65","author":"Edelen","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"3","key":"10.1016\/j.jamda.2026.106178_bib34","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jpainsymman.2016.10.369","article-title":"Hospice use and pain management in elderly nursing home residents with cancer","volume":"53","author":"Hunnicutt","year":"2017","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jamda.2026.106178_bib35","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s40266-019-00650-3","article-title":"Adjuvant use and the intensification of pharmacologic management for pain in nursing home residents with cancer: data from a US national database","volume":"36","author":"Liu","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jamda.2026.106178_bib36","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1007\/s11135-017-0584-6","article-title":"Confounding and collinearity in regression analysis: a cautionary tale and an alternative procedure, illustrated by studies of British Voting Behaviour","volume":"52","author":"Johnston","year":"2018","journal-title":"Qual Quant"},{"key":"10.1016\/j.jamda.2026.106178_bib38","article-title":"A nursing home clinician survey to explain gabapentinoid increases","volume":"26","author":"Winter","year":"2024","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2026.106178_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000525343","article-title":"Social connectedness among long-stay nursing home residents with Alzheimer\u2019s and dementia: exploring individual and facility-level variation","volume":"51","author":"Lapane","year":"2022","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.jamda.2026.106178_bib40","first-page":"40","article-title":"Depression, anxiety, and pain among newly admitted nursing home residents","volume":"5","author":"Ulbricht","year":"2019","journal-title":"J Nurs Home Res Sci"},{"key":"10.1016\/j.jamda.2026.106178_bib41","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1532-5415.2011.03418.x","article-title":"Effect of a pharmacist-led multicomponent intervention focusing on the medication monitoring phase to prevent potential adverse drug events in nursing homes","volume":"59","author":"Lapane","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106178_bib43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/workar\/waaa021","article-title":"The psychological consequences of the COVID-19 on residents and staff in nursing homes","volume":"6","author":"Mo","year":"2020","journal-title":"Work Aging Retire"},{"key":"10.1016\/j.jamda.2026.106178_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2020.113294","article-title":"High depression and anxiety in people with Alzheimer\u2019s disease living in retirement homes during the COVID-19 crisis","volume":"291","author":"El Haj","year":"2020","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jamda.2026.106178_bib45","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/jgs.18116","article-title":"Behavioral symptoms, depression symptoms, and medication use in Michigan nursing home residents with dementia during COVID -19","volume":"71","author":"Coe","year":"2023","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2026.106178_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.1020023","article-title":"Effect of the COVID-19 pandemic on the psychotropic drug consumption","volume":"13","author":"Benistand","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jamda.2026.106178_bib47","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jagp.2022.09.009","article-title":"Did the COVID-19 pandemic affect the use of antipsychotics among nursing home residents with ADRD?","volume":"31","author":"Yan","year":"2023","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2026.106178_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jamda.2023.09.009","article-title":"Psychotropic, anticonvulsant, and opioid use in assisted living residents before and during the COVID-19 pandemic","volume":"25","author":"Maxwell","year":"2024","journal-title":"J Am Med Dir Assoc"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586102600068X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152586102600068X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T23:57:46Z","timestamp":1780617466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152586102600068X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S152586102600068X"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2026.106178","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Prevalence of Central Nervous System-Active Polypharmacy in US Nursing Homes","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Medical Directors Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jamda.2026.106178","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Post-Acute and Long-Term Care Medical Association.","name":"copyright","label":"Copyright"}],"article-number":"106178"}}